- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Designing Multimedia Patient Education to Overcome COVID-19 Vaccine Hesitancy
How can health care systems talk about the issue of COVID-19 vaccine hesitancy with their patients? On this episode of Managed Care Cast, Pat Salber, MD, MBA, of The Doctor Weighs In, interviews the developer of interactive, people-centered, multimedia, educational programs for Wolters Kluwer Health.
Addressing vaccine hesitancy, which may take the form of refusing a vaccine or putting oneself in the “wait and see” camp while thinking it over, has never been more urgent as health authorities race to try and vaccinate as much of the population as possible against the virus that causes COVID-19 in 2021.
On this episode of Managed Care Cast, Pat Salber, MD, MBA, of The Doctor Weighs In, discusses education for patients on the topic of vaccine hesitancy and COVID-19. Her guest is Eve Gaus, who directs the development of interactive, people-centered, multimedia, educational programs for Wolters Kluwer Health. The programs are used by health care systems to address questions raised by patients about the vaccines, how they were approved, how they work, and more.
Listen above or through one of these podcast services:
Prenatal PFAS Exposure Alters Infant Vaccine-Related Immune Cells
August 1st 2025Prenatal exposure to per- and polyfluoroalkyl substances (PFAS), a class of persistent environmental pollutants, was linked to significant shifts in infant T helper cell development, raising concerns about long-term effects on vaccine response, immune regulation, and disease susceptibility.
Read More
Updated mRNA Vaccines Against JN.1 Show Strong Safety Signal in Real-World Data
July 31st 2025A nationwide Danish cohort study demonstrated no increased risk of serious adverse events following vaccination with JN.1-updated mRNA COVID-19 vaccines, reinforcing their safety profile and supporting continued use in high-risk populations amid ongoing viral evolution.
Read More
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More
